Increasingly stringent International Pharmaceutical regulations dictate the need for consistent quality standards at all stages of industrial production. In order to address this situation, IPS has created a completely dedicated division, focused on R&D and industrial production of SURINERTS® pellets for pharmaceutical use, which is in compliance with current international requirements. IPS’s corporate initiative aims to develop our strength in technological concerns, improving quality and range of products.
This initiative is founded on over 50 years of leadership, the highest quality achievements and dedicated contributions of our employees in the field of controlled release oral pharmaceutical products and critical excipients production. We will continue to assure our current and future customers the highest quality and performance from IPS products and services.
Surinerts ® products are fully in compliance with: USP and EP current editions. High quality standards are guaranteed by analytical and microbiological quality control tests, throughout all the manufacturing steps.
All the analytical tests are carried out both by an internal Analytical Laboratory and by external validated laboratories.
Certificate of Analysis are issued by our QC and approved by our QA.
Production is made in San Giuliano Milanese (Milan) plant and includes storage and quarantine areas, analytical laboratory, research and development departments. Approved (ISO 9001:2015).
I.P.S. – International Products & Services founded in 1976 is part of the GP GROUP OF COMPANIES, fully owned by PADUSA S.p.A., an Italian family holding whose diversified activities extend to: